Table 5: Sensitivity analysis of the effect of Baduanjin exercise to clinical patients or healthy participants.

Before sensitivity analysisAfter sensitivity analysis
ComparisonsMD (model)
95% CI
P value (%) Method of sensitivity analysisComparisonsMD (model) 95% CIP value (%)

Baduanjin + routine treatment versus routine treatment for TC in clinical patients
 5−0.56 (random)
(−0.74, 0.37)
86Remove Zhang 2005 and Zhang 20083−0.83 (fixed)
(−1.04, −0.62)
0
Baduanjin + routine treatment versus other exercises for TC in clinical patients
 3−0.01 (random)
(−0.25, 0.24)
68Remove Zhang 20082−0.17 (fixed)
(−0.45, 0.11)
0
Baduanjin + routine treatment versus routine treatment for HDL-C in clinical patients
 50.04 (random) (−0.1, 0.18)73Remove Zhang 200840.12 (fixed) (0.06, 0.18)51
Baduanjin versus no treatment for HDL-C in health adults
 90.13 (random) (0.06, 0.21)56Remove Liu et al. 200680.16 (fixed) (0.11, 0.21)19
Baduanjin + routine treatment versus routine treatment for TG in clinical patients
 4−0.77 (random)
(−1.97, 0.42)
94Remove Wang et al. 20073−0.16 (fixed) (−0.49, 0.17)0
Baduanjin + routine treatment versus other exercises plus routine treatment for LDL-C in clinical patients
 30.08 (random)
(−0.43, 0.58)
88Remove Zhou et al. 201120.29 (fixed) (0.05, 0.53)53